FDA Approves Gamifant for MAS in Still’s Disease
A New Dawn in Pediatric Care: Gamifant’s Breakthrough Approval for Macrophage Activation Syndrome It’s a moment we’ve all been waiting for in the world of pediatric rheumatology, truly a significant stride forward. The U.S. Food […]
